0001477932-26-000845
SEC filingAgentix Corp. reported a net loss of $79K for Q3 2026 (period ending December 31, 2025), driven by a loss from operations of $67K. Total operating expenses were $67K, consisting primarily of professional fees ($51K) and general and administrative expenses ($17K), with no research and development costs. The company's balance sheet shows total assets of $6K, consisting entirely of cash, while total liabilities stand at $3.5M, resulting in a stockholders' deficit of $3.5M. Cash flow from operations was negative $123K, partially offset by $110K in financing activities from debt issuance, resulting in a net cash increase of $2K. The company maintains minimal cash reserves of $6K while carrying significant liabilities, primarily accounts payable to related parties ($2.3M).
Agentix Corp. reported a net loss of $79K for the third quarter of fiscal year 2026 (period ending December 31, 2025). The company's operations resulted in a loss of $67K, with total operating expenses amounting to $67K. These expenses were comprised of professional fees ($51K) and general and administrative expenses ($17K), with no research and development costs reported. Other expenses included foreign exchange loss ($3K) and interest expense ($14K), totaling $11K in other loss. The company reported no income tax provision. The comprehensive loss totaled $80K, including a $1K change in foreign currency translation. No prior period comparison data is provided in the filing for QoQ analysis.
No revenue figures are disclosed in the 10-Q filing for Agentix Corp. The income statement shows only expense items and losses, with no revenue line items present in either the XBRL data or document text. The company's operations appear to be in a pre-revenue stage, with all financial activity focused on expense management and financing activities. No segment breakdown, geographic mix, or growth drivers related to revenue generation are mentioned in the filing.
Agentix Corp. reported negative operating and net income margins due to the absence of revenue. The company incurred $67K in operating expenses, resulting in an operating loss of $67K. The cost structure consists entirely of operating expenses, with professional fees representing 76% of total operating expenses ($51K of $67K). General and administrative expenses accounted for the remaining 24% ($17K). No gross margin or operating margin percentages can be calculated as no revenue figures are provided. The company shows no research and development spending during the period.
Cash flow from operating activities was negative $123K, driven by a net loss of $409K adjusted for a $21K gain on settlement of accounts payable and changes in working capital. Investing activities showed no cash flow. Financing activities provided $110K from debt issuance. Foreign exchange effects added $15K, resulting in a net cash increase of $2K. The balance sheet shows total assets of $6K (all cash), with total liabilities of $3.5M, creating a stockholders' deficit of $3.5M. Current liabilities of $3.5M include accounts payable ($707K), accounts payable to related parties ($2.3M), note payable to related party ($353K), and accrued expenses ($124K). The company's liquidity position is constrained with minimal cash reserves.
No forward-looking statements, management guidance, strategic priorities, or specific risk factors are disclosed in the provided 10-Q filing content. The document contains only historical financial data without commentary on future expectations, business strategy, or operational plans. Investors should note the company's significant liabilities relative to assets and negative cash flow from operations as key financial considerations.